Immunotherapy added to chemotherapy improves pathological complete response in early triple negative breast cancer from immunotherapy in cancer Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Prof Peter Schmid presents data from theKEYNOTE-522 trial during a press conference at the 2019 ESMO congress.nnThis was a phase III trial looking at immunotherapy added to chemotherapy in early triple negative breast cancer.nnSign up to ecancer for free to receive tailored email alerts for more videos like this.necancer.org/account/register.php
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)